Legal Representation
Attorney
Andrew Auderieth
USPTO Deadlines 5 active 5 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Mar 17, 2023 | 843 days overdue | Low | No |
OPPOSITION
Notice of Publication |
NPUB | May 04, 2023 | 795 days overdue | Medium | Until Jun 04, 2023 |
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Nov 30, 2023 | 585 days overdue | High | Until May 30, 2024 |
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Mar 29, 2024 | 465 days overdue | Critical | Until Jun 29, 2024 |
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Mar 29, 2024 | 465 days overdue | Critical | Until Jun 29, 2024 |
Application History
33 eventsDate | Code | Type | Description |
---|---|---|---|
Sep 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Sep 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 21, 2024 | ALIE | A | ASSIGNED TO LIE |
Aug 21, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Aug 21, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 21, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Aug 21, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Mar 9, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Dec 29, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Dec 29, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
Dec 29, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
Dec 9, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Dec 9, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Nov 30, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Nov 30, 2023 | IUAF | S | USE AMENDMENT FILED |
May 30, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 2, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 2, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Mar 2, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Mar 2, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Mar 2, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Feb 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 26, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Aug 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
Aug 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Aug 26, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Nov 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 19, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 044
Providing medical information in the field of vision care; providing an internet website for medical professionals and medical patients featuring medical analysis of treatments; providing an internet website featuring reporting information on laser eye surgery; medical services in the nature of tracking and analyzing outcomes following laser eye surgery; medical services in the nature of tracking and analyzing outcomes following astigmatic surgery; medical services in the nature of tracking and analyzing outcomes following treatment plans for intraocular lens calculations
First Use Anywhere:
Jan 15, 2023
First Use in Commerce:
Jan 15, 2023
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ANALYTICS"